Search for Amarin's Vascepa Prevents Second And Third Heart Attacks In Analysis - Stat on Bing

Amarin's Vascepa prevents second and third heart attacks in analysis STATWith Vascepa, first heart problems were cut by 25 percent, second ones by 32 percent, third events by 31 percent, and fourth events by 48 percent.View full coverage on Google News

BING NEWS:
  • Study: Women with heart disease prescribed cholesterol-lowering drugs less often than men
    Women with heart disease may be prescribed cholesterol-reducing statins less frequently than men, contravening recommended treatment guidelines, according to new research released Thursday.
    04/24/2024 - 11:36 pm | View Link
  • Amarin's (AMRN) Q1 Earnings Top, Vascepa Sales Fall
    Image Source: Zacks Investment Research U.S. product revenues from Vascepa,the company’s sole marketed drug, were $82.3 million, down 12% from the year-ago quarter’s level. Lower volumes were ...
    05/3/2023 - 8:47 am | View Link
  • UPDATE 1-U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents
    WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against generic ...
    06/20/2021 - 12:59 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News